HCL Tech, Zydus Life, Marico among buzzing stocks as SENSEX jumps over 500 pts, NIFTY50 up 0.8% in noon deals
The stock of Zydus Lifesciences climbed nearly 3.16% to hit a 52-week high of ₹1,134.50 per equity share on the NSE, as it signed a Memorandum of Understanding (MoU) with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test (MCD) in India.
The stock of Zydus Lifesciences climbed nearly 3.16% to hit a 52-week high of ₹1,134.50 per equity share on the NSE, as it signed a Memorandum of Understanding (MoU) with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test (MCD) in India.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
